#daraprim — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #daraprim, aggregated by home.social.
-
Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy - Enlarge / Martin Shkreli. (credit: Getty | Drew Angerer)
The p... - https://arstechnica.com/?p=1938723 #pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #science #policy #turing #vyera
-
Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy - Enlarge / Martin Shkreli. (credit: Getty | Drew Angerer)
The p... - https://arstechnica.com/?p=1938723 #pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #science #policy #turing #vyera
-
Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy - Enlarge / Martin Shkreli. (credit: Getty | Drew Angerer)
The p... - https://arstechnica.com/?p=1938723 #pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #science #policy #turing #vyera
-
Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy - Enlarge / Martin Shkreli. (credit: Getty | Drew Angerer)
The p... - https://arstechnica.com/?p=1938723 #pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #science #policy #turing #vyera
-
Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy - Enlarge / Martin Shkreli. (credit: Getty | Drew Angerer)
The p... - https://arstechnica.com/?p=1938723 #pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #science #policy #turing #vyera
-
Ars Technica: Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy https://arstechnica.com/?p=1938723 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #Science #Policy #Turing #Vyera
-
Ars Technica: Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy https://arstechnica.com/?p=1938723 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #Science #Policy #Turing #Vyera
-
Ars Technica: Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy https://arstechnica.com/?p=1938723 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #Science #Policy #Turing #Vyera
-
Ars Technica: Pharma company behind Shkreli’s infamous 4,000% price hike files for bankruptcy https://arstechnica.com/?p=1938723 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #martinshkreli #pricegouging #bankruptcy #daraprim #Science #Policy #Turing #Vyera
-
CW: uspol
From 20 Jan: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a congressional he... https://arstechnica.com/science/2023/01/ftc-shkreli-may-have-violated-lifetime-pharma-ban-should-be-held-in-contempt/ #daraprim #drug-discovery #druglike #pharma #pharmaceutical-industry #policy #science #shkreli
-
CW: uspol
From 20 Jan: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a congressional he... https://arstechnica.com/science/2023/01/ftc-shkreli-may-have-violated-lifetime-pharma-ban-should-be-held-in-contempt/ #daraprim #drug-discovery #druglike #pharma #pharmaceutical-industry #policy #science #shkreli
-
CW: uspol
From 20 Jan: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a congressional he... https://arstechnica.com/science/2023/01/ftc-shkreli-may-have-violated-lifetime-pharma-ban-should-be-held-in-contempt/ #daraprim #drug-discovery #druglike #pharma #pharmaceutical-industry #policy #science #shkreli
-
CW: uspol
From 20 Jan: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a congressional he... https://arstechnica.com/science/2023/01/ftc-shkreli-may-have-violated-lifetime-pharma-ban-should-be-held-in-contempt/ #daraprim #drug-discovery #druglike #pharma #pharmaceutical-industry #policy #science #shkreli
-
FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1911591 #pharmaceuticalindustry #drugdiscovery #daraprim #druglike #science #shkreli #policy #pharma
-
FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1911591 #pharmaceuticalindustry #drugdiscovery #daraprim #druglike #science #shkreli #policy #pharma
-
FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1911591 #pharmaceuticalindustry #drugdiscovery #daraprim #druglike #science #shkreli #policy #pharma
-
FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1911591 #pharmaceuticalindustry #drugdiscovery #daraprim #druglike #science #shkreli #policy #pharma
-
FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1911591 #pharmaceuticalindustry #drugdiscovery #daraprim #druglike #science #shkreli #policy #pharma
-
Ars Technica: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt https://arstechnica.com/?p=1911591 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #Drugdiscovery #daraprim #Druglike #Science #Shkreli #Policy #Pharma
-
Ars Technica: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt https://arstechnica.com/?p=1911591 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #Drugdiscovery #daraprim #Druglike #Science #Shkreli #Policy #Pharma
-
Ars Technica: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt https://arstechnica.com/?p=1911591 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #Drugdiscovery #daraprim #Druglike #Science #Shkreli #Policy #Pharma
-
Ars Technica: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt https://arstechnica.com/?p=1911591 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #Drugdiscovery #daraprim #Druglike #Science #Shkreli #Policy #Pharma
-
@angry_prof39 @furvent @Shibanarchiste Toujours pareil : plus de demande (le diabète augmente) donc il y a des enfoir*s qui en profitent pour se faire du beurre sur le dos des malades.
Voir Martin Shkreli #daraprim -
@angry_prof39 @furvent @Shibanarchiste Toujours pareil : plus de demande (le diabète augmente) donc il y a des enfoir*s qui en profitent pour se faire du beurre sur le dos des malades.
Voir Martin Shkreli #daraprim -
Martin Shkreli out of prison over 2 years early, moved to halfway house - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1855035 #pharmaceuticalindustry #daraprim #science #release #shkreli #policy #prison #fraud
-
Shkreli’s infamous 4,000% price hike gets him a lifetime pharma ban - Enlarge / Martin Shkreli. (credit: Getty | Drew Angerer)
A fed... - https://arstechnica.com/?p=1826072 #pharmaceuticalindustry #daraprim #science #shkreli #wutang
-
@levoilaux1 La bêtise Monsieur c'est d'affirmer des opinions ou pire comme c'est le cas de cette urgentiste, de stigmatiser des gens en les traitant d'incultes sans juger opportun d'apporter des arguments solides... Il est temps à mon avis de vous renseigner un peu sur le monde de la pharmaceutique et de ses lien strès forts au pouvoir politique actuel #Médiator #Distilbène #Vioxx #Depakine #Daraprim https://peertube.dc.pini.fr/w/iKcXHCC9CxebxThKohUrQ9 https://peertube.dc.pini.fr/w/433qfbAL7j3BRSHAjcVe5v https://peertube.dc.pini.fr/w/dYoAt4yKTiJ46X5w2mn1o1 https://www.youtube.com/watch?v=VClhhSlzpQw
-
Shkreli’s infamous price-gouging scheme finally shut down in $40M settlement - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1819411 #pharmaceuticalindustry #turingpharmaceuticals #daraprim #science #newyork #shkreli #policy #vyera #ftc
-
Le vaccin Cubain est efficace à 92%, même sur les variants. Pourquoi le gouvernement ne me le proposerait pas ? Cuba produit un vaccin pour sa population sans intérêt commercial en arrière plan. Il est évident de comprendre qu'il n'a aucun intérêt à mentir ou à empoisonner pour s'enrichir, contrairement à Big Pharma qui s'illustre régulièrement par sa cupidité et son absence de déontologie. #Médiator #Distilbène #Vioxx #Depakine #Daraprim ...
-
Le vaccin Cubain est efficace à 92%, même sur les variants. Pourquoi le gouvernement ne me le proposerait pas ? Cuba produit un vaccin pour sa population sans intérêt commercial en arrière plan. Il est évident de comprendre qu'il n'a aucun intérêt à mentir ou à empoisonner pour s'enrichir, contrairement à Big Pharma qui s'illustre régulièrement par sa cupidité et son absence de déontologie. #Médiator #Distilbène #Vioxx #Depakine #Daraprim ...
-
Shkreli directing notorious pharma co. from prison. It’s still losing millions - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a Congressional hearing. (c... more: https://arstechnica.com/?p=1470247 #pharmaceuticalindustry #drugpricing #phoenixus #daraprim #science #shkreli #policy #turing #fraud